Similarly, primary EGFR‐mutated lung cancer cells (MGH119) showed higher CEACAM5 and epithelial marker CLDN1 expression but lower mesenchymal marker CDH2 expression than their EGFR‐TKI gefitinib‐resistant counterparts (MGH119GR) (Figure 4B). Here, EGFR is linked to lung carcinoma.